@article{e1d6dd147115417c8819e1986d02424e,
title = "Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.",
keywords = "idiopathic pulmonary fibrosis, interstitial lung disease, progressive pulmonary fibrosis, pulmonary fibrosis, treatment",
author = "Mackintosh, {John A.} and Gregory Keir and Troy, {Lauren K.} and Holland, {Anne E.} and Christopher Grainge and Chambers, {Daniel C.} and Debra Sandford and Jo, {Helen E.} and Ian Glaspole and Margaret Wilsher and Goh, {Nicole S.L.} and Reynolds, {Paul N.} and Sally Chapman and Mutsaers, {Steven E.} and {de Boer}, Sally and Susanne Webster and Yuben Moodley and Corte, {Tamera J.}",
note = "Funding Information: This position statement was supported by the Centre of Research Excellence in Pulmonary Fibrosis (funded by the NHMRC [GNT1116371 and GNT2015613], Lung Foundation Australia, anonymous philanthropy and Foundation partner Boehringer Ingelheim), The Thoracic Society of Australia and New Zealand and Lung Foundation Australia. Open access publishing facilitated by The University of Queensland, as part of the Wiley - The University of Queensland agreement via the Council of Australian University Librarians. Publisher Copyright: {\textcopyright} 2024 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.",
year = "2024",
month = feb,
doi = "10.1111/resp.14656",
language = "English",
volume = "29",
pages = "105--135",
journal = "Respirology",
issn = "1323-7799",
publisher = "John Wiley & Sons",
number = "2",
}